Background: Centenarians display a characteristic autoantibody profile, this being the absence of organ-specific autoantibodies and an increase in non-organ-specific autoantibodies without any full-blown autoimmune disease. Objective: Antibodies directed to the nuclear protein poly(ADP-ribose) polymerase (PARP) were frequently found in the sera of patients affected by autoimmune diseases. This study aims at investigating the presence of circulating autoantibodies directed against PARP-1 in normal subjects, and searching for a possible correlation between level of circulating autoantibodies and age. Methods: The presence of antibodies to PARP was monitored by ELISA according to a previously developed protocol. Data were analysed by parametric statistics (unpaired t test, χ2 test). Results: Our study performed on 33 centenarians and 66 subjects of age ranging from 12 to 80 years shows that circulating autoantibodies to the nuclear enzyme PARP, previously described in autoimmune diseases, are present in the sera of normal healthy people and increase with age. Conclusions: Taking into account the role of PARP-1 in DNA damage and apoptosis, the data are compatible with Grabar’s hypothesis, which proposed several decades ago that ‘autoreactive antibodies represent a physiological system for disposing the products of metabolism and catabolism’, thereby helping to attain longevity.

Keywords:
Autoimmunity, Centenarians, Grabar’s hypothesis, Parametric statistics, Poly(ADP-ribose) polymerase
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.